Latino patients usually have 2 last names. Our first last name is he paternal last name and our second last name is the maternal. There is a space in between. Some of us (for simplicity) prefer just going by just the first last name. There are many Hispanic patients in the US..

Redlining may have stopped but we still face its effects. Dr Patricia L. Turner, MD, MBA, FACS American College of Surgeons lecture at #SSO2024 highlighting the importance of mitigating health disparities in surgical practice and cancer care.

SurgOnc research team in Atlanta! (missing Dr. Armando Sardi, MD, FACS and Mary Caitlin King) Great last day at #SSO2024 with top notch presentations Society of Surgical Oncology

A lot of inspiration from bright and outstanding presentations at #SSO2024 in Atlanta. Congratulations Luis Felipe Falla on an excellent talk. These days I was so happy to met new people as well as old friends.

#OvarianCancer is on the rise, with cases set to increase 55% by 2050. Knowing these five facts about #OvarianCancer can save lives. #WorldOvarianCancerDay is May 8. #NoWomanLeftBehind #WOCD2024

Shifting the focus on survivorship. From “if” to life. Points well made by Dr Cecile A. Ferrando, MD MPH (she/her) at National Comprehensive Cancer Network (NCCN) Oncology Policy Summit on Sexual and Reproductive Health. Choosing to listen, assumptions aside!

So glad to have witnessed such great discussions! Grateful for these spaces National Comprehensive Cancer Network (NCCN) 👏🏽 @drkovalikw look at us photobombing 😅

Pelvic pain 💎💎 by Dr. Jorge F. Carrillo MD, FACOG 🇺🇸🇵🇪🇨🇴 on central sensitization (CS) and endometriosis ✍️ - CS and nociplastic pain are not synonyms - CS should be considered when patients don’t respond to peripheral therapies and before performing surgery! Great talk! Thanks AAGL FECOLSOG

Among 1,476 people with syphilis during pregnancy, 42.1% were inadequately or not treated, despite 82.2% receiving prenatal care more than 30 days before pregnancy outcome. Read the full article for FREE at ow.ly/exfn50RISqN

#WAGO2024 day 1 Great presentation by Dr Sergei Iugai, MD showcasing our findings in time to adjuvant chemotherapy after CRS/HIPEC for primary #OvarianCancer Well done 👏🏽. Thankful to be here!

Excited to see the great gynecological oncology research other IMGs are doing At #WAGO2024 Western Association of Gynecologic Oncologists Congratulations to Drs Jian Li (MD Anderson Cancer Center), Marwa Aljardali, and Joe Haydamous 👏🏽💫 well done!

In Press: Exploring health-related quality of life (HRQL) in primary #OvarianCancer patients via a phase 2 trial comparing cytoreductive surgery (CRS)+HIPEC vs CRS+IP chemotherapy revealed no differences or long-term HRQL impact Luis Felipe Falla ow.ly/wZv050SyhhL @SKMaithel

🔥 Long-awaited results from the HOT trial! 🎉Interesting insights on quality of life after #HIPEC as initial treatment for #OvarianCancer Andrei Nikiforchin, MD Felipe Lopez-Ramirez Armando Sardi, MD, FACS Vadim Gushchin, MD, FACS Teresa Diaz-Montes Vladislav Kovalik Sergei Iugai, MD SGO Society of Surgical Oncology

Splenectomy as a part of cytoreductive surgery in #ovariancancer: systematic review and meta-analysis ✅ bit.ly/45YyzNv Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

Current QoL questionnaires do not cover many issues that are important to patients undergoing CRS and HIPEC ➡️22 questions did not overlap with current QoL questionnaires Much needed and novel manuscript by Armando Sardi, MD, FACS Vadim Gushchin, MD, FACS Luis Felipe Falla Mercy Medical Center

Congratulations! 👏🏽 Today is your day Drs! 🎉 Mecker G Möller MD FACS MAMSE Alissa Greenbaum Lana Bijelic Sherif Abdel-Misih Armando Sardi, MD, FACS Vadim Gushchin, MD, FACS

#WeeklyPodcast 🎙️Hear Drs. Lot Aronson and Willemien van Driel discuss the Overall Survival analysis of #OVHIPEC 1 @ bit.ly/3yXbpv5 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc René Pareja